January 2018 in “대한피부과학회지” Stopping erlotinib improved severe hair loss and skin issues in a patient.
20 citations
,
March 2019 in “Case Reports in Dermatology” IL-17 inhibitors for psoriasis may cause unexpected hair loss.
9 citations
,
February 2012 in “Cancer Chemotherapy and Pharmacology” The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.
7 citations
,
December 1956 in “Science” 1 citations
,
December 1956 in “Science” June 2025 in “Acta Dermato Venereologica” Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.
February 2011 in “Journal of Investigative Dermatology” New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.
April 2021 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” Patients with lupus nephritis and COVID-19 can improve with proper treatment.
July 2024 in “Journal of Investigative Dermatology” July 2024 in “Journal of Investigative Dermatology”
April 2017 in “Journal of Investigative Dermatology” Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.
5 citations
,
August 1981 in “Archives of Dermatology” Alopecia areata may be caused by the immune system attacking hair follicles.
8 citations
,
February 2022 in “Journal of Clinical Medicine” Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
July 2023 in “Dermatology practical & conceptual” Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.
8 citations
,
February 2005 in “British Journal of Haematology” Chemotherapy caused the patient's hair to have alternating thick and thin segments.
January 2026 in “Archives of Dermatological Research” Severe COVID-19 increases the risk of hair loss.
2 citations
,
January 2015 in “Chinese Medical Journal” Lithium can cause skin discoloration even at normal levels, so monitor for signs of intoxication.
November 2024 in “NeoReviews” An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.
2 citations
,
December 2010 in “Zhonghua neifenmi daixie zazhi” AHST shows promise for treating type 1 diabetes but needs more research before widespread use.
January 2021 in “International Journal of Immunology” Early detection and aggressive treatment of severe lung complications in lupus are crucial to improve survival.
June 2023 in “F1000Research” A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.
23 citations
,
November 2024 in “Nature”
Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.
7 citations
,
September 1997 in “PubMed”
24 citations
,
February 2007 in “International Journal of Dermatology” A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.
9 citations
,
September 1989 in “PubMed” Sudanese children with severe malnutrition have low selenium levels, which may affect their recovery.
Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.
3 citations
,
April 1977 in “PubMed” The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.
2 citations
,
September 2024 in “PLoS ONE” This study examines the cytotoxic effects of bendamustine (BDM) on adult T-cell leukemia (ATL) cells, both alone and in combination with novel agents such as tucidinostat, valemetostat, and ABT-737. The combination of BDM and tucidinostat showed promising results, enhancing cytotoxicity without significant hematological toxicity in a murine model and significantly slowing tumor growth in mice. The study suggests that this combination could potentially improve outcomes for patients with relapsed or refractory ATL, highlighting the need for further clinical trials to explore its efficacy and safety.
1 citations
,
August 1995 in “Archives of Disease in Childhood” Minoxidil helped a boy regrow his hair after intense chemotherapy for leukaemia.